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Against a background of rapid scale-up of 
new policies and guidelines in the context of 
weak health systems in low/middle-income 
countries (LMIC), implementation research 
is especially important for understanding 
the ‘evidence-implementation’ gap. Imple-
mentation research investigates the various 
factors that affect how a new health policy or 
intervention may be implemented in usual 
practice settings and the contextual factors 
that affect implementation at scale.1–4 A wide 
range of qualitative and quantitative methods 
can be used in implementation research 
including: pragmatic trials, quality improve-
ment studies, participatory action research 
and mixed methods evaluation studies where 
both quantitative and qualitative methods of 
data collection and analysis are used in the 
same study.1 
There has been an increase in funder 
requests for research proposals that document 
and evaluate implementation strategies and 
impacts of large-scale health interventions 
aimed at supporting the delivery of health 
services, programmes and policies.5 The 
concomitant emergence of ‘global health’ as 
a field within North American and European 
universities (referred to here as the ‘Global 
North’) has led to a plethora of institutions 
who commission, undertake and collaborate 
on implementation research within LMIC 
settings (referred to here as the ‘Global 
South’), sometimes as part of countries’ over-
seas development assistance (ODA).6 7
Recently, there is a welcome, although 
gradual shift towards greater commissioning 
of research institutions in the Global South 
to undertake research on programmes 
implemented in and/or issues affecting the 
Global South.8 However, the commissioning 
agencies are commonly situated in the Global 
North. In this opinion piece, we reflect criti-
cally on the inherent tensions involved with 
undertaking such commissioned imple-
mentation research and the potential for 
North-South power differentials to add to 
this complexity.7 9 Many of the dilemmas 
raised may well apply to other types of health 
research. Our perspectives emerge from our 
personal and collective experiences as health 
systems researchers working in LMIC settings.
THe poliTiCal ConTexT of Commissioning 
and underTaking implemenTaTion researCH
In many LMICs, health sectors are typically 
dependent on ODA for the funding and 
Summary box
 ► Rapid scale-up of new policies and guidelines, in the 
context of weak health systems in low/middle-in-
come countries (LMIC), has led to greater interest 
and funding for implementation research.
 ► Implementation research in LMICs is often commis-
sioned by institutions from high-income countries 
but increasingly undertaken by LMIC-based re-
search institutions.
 ► Commissioned implementation research to evaluate 
large-scale, donor-funded health interventions in 
LMICs may hold tensions with respect to the inter-
ests of the researchers, the commissioning agency, 
implementers and the country government.
 ► We propose key questions that could help research-
ers navigate and minimise the potential conflicts of 
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the evaluation of health programmes, which often take 
the form of large-scale health service and programme 
implementation, geared towards addressing priority 
health problems. Research agencies may be contracted 
to undertake evaluation research, be it by appointment 
or via a competitive bidding process.10 Undertaking such 
commissioned implementation research has inherent 
tensions stemming from differences in objectives 
(explicit and implicit) between the different stakeholders 
involved; including commissioning agencies, funders of 
the implementation programme, researchers and the 
government of the host country.
In an LMIC context, often with weak health systems 
and governance structures, there may be a dependence 
on donor funding for implementation, scale-up and 
sustained delivery of health services and programmes. 
Ethical and political dilemmas of undertaking commis-
sioned research have been acknowledged by others.11 12 
Mumtaz et al12 have argued that projects commonly have 
unarticulated goals alongside explicit health outcomes 
which influence how and which research findings are 
shared, including: ‘maintaining positive relationships 
between donors and governments, keeping money 
flowing, and maintaining the appearance of success.’
We propose two key questions we feel can help 
researchers be aware of, anticipate and potentially mini-
mise the complexities and pitfalls associated with commis-
sioned implementation research,11 especially in a setting 
where there may be a North-South power differential: 
(1) Who is commissioning the research and how can 
the independence and integrity of the research process 
be maintained? (2) What is the purpose of the research 
and how will the findings be used? Boxes 1 and 2 contain 
illustrative vignettes reflecting lessons we have learnt as 
health systems researchers from an LMIC setting, who 
through competitive processes, have undertaken inde-
pendent implementation research of complex health 
system interventions.
Who is commissioning the research and how can the 
independence and integrity of the research process be 
maintained?
Implementation research can be commissioned by 
a variety of organisations including national govern-
ments, private sector companies, implementing agen-
cies, bilateral and multilateral agencies.10 It is important 
for researchers to reflect on who the commissioning 
agency is and on the potential complications this may 
have for the independence and integrity of the research. 
For instance, it is not uncommon for implementation 
research to be commissioned by agencies which are 
themselves both funding and implementing health 
programmes being evaluated. These agencies may also 
themselves be involved with developing global guidelines 
for the interventions they are having evaluated. Under-
standably, these agencies may therefore have a particular 
interest in showing a positive impact or other results that 
would support their objectives. It may be difficult for the 
commissioned researchers to establish their independ-
ence at an early stage, by for instance asking critical ques-
tions that may further shape the research scope and by 
ensuring the research methodology is sufficiently inde-
pendent. In box 1 our vignette illustrates the dilemma 
of ensuring independence in data collection methods, in 
a situation where the boundaries between the key stake-
holders were fluid.
We illustrate in box 1 the importance of establishing 
independence early in the commissioning processes, to 
uphold research integrity. Important considerations are 
whether the commissioning agency is also the funding 
or implementing agency and thus stands to potentially 
gain or lose future funding for the programme being 
researched, based on the direction of the findings, and 
whether the interviewees are directly or indirectly funded 
by the commissioning agency.
Most agencies commissioning implementation 
research strive to appoint independent researchers 
to carry out the research. However, as illustrated, 
there are instances in which members of the funding 
or programme implementation team are involved in 
Box 1 Who is commissioning the research and how can 
the independence and integrity of the research process be 
maintained?
A multilateral agency has advocated for countries to scale up outreach 
services for child immunisations in ‘hard to reach’ areas. The agency 
has supported several countries in sub-Saharan Africa to implement 
this intervention and they have now commissioned an independent 
evaluation of the intervention. Following a competitive process, a 
research institution from the Global South is awarded the research 
grant.
During the planning meeting with the commissioning agency the 
researchers discuss their plans for undertaking the evaluation. 
The agency informs them that they would like their country staff to 
accompany the researchers during their fieldwork, including sitting 
in on interviews with stakeholders. They argue that this independent 
evaluation could be a learning opportunity for their staff. The 
commissioned researchers acknowledge that the country agency 
staff have a role to play in facilitating the logistics of the in-country 
fieldwork (such as assisting with setting up interview times and 
venues with local stakeholders and providing relevant documentation 
for review). However, the researchers feel that the presence of the 
agency staff in interviews represents a conflict of interest, could 
inhibit honest dialogue with those interviewed and thereby poses a 
threat to the independence of the research and thus to the integrity of 
the data collected. Following discussion, the commissioning agency 
agrees to the request for them not to be present during interviews.
The researchers also considered the ethical principle of non-
malfeasance, to ensure the research does not cause harm. The 
commissioning agency was also supporting the salaries of some 
stakeholders being interviewed as part of the research. These 
participants may be particularly vulnerable to negative consequences 
(perceived or real) should they be open in interviews about the 
shortcomings of the programme being evaluated. The researchers 
have to ensure that they sufficiently anonymise the data and research 
report, so as to protect the identity of participants.
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designing the research, selecting research sites and 
even assisting with data analysis and interpretation. This 
situation greatly increases the influence of the commis-
sioning agency in the research process, thus potentially 
influencing the outcomes. Where funders are involved in 
this way, we suggest that the commissioning agency and 
the researchers work towards clear guidelines regarding 
their respective roles and responsibilities. This should 
include discussion of the extent to which the researchers 
have the final autonomy for the collection, interpretation 
and reporting of findings; and what mechanisms will be 
put in place to ensure the independence and integrity of 
the research process.
What is the purpose of the research and how will the findings 
be used?
The commissioning of implementation research can serve 
multiple purposes: the implementing agency (govern-
ment, non-governmental organisation or international 
implementing partner) may be required to report to a 
donor agency about progress with implementation or 
impact, as a requirement for continued funding; or an 
assessment of a pilot phase may be required before a 
decision can be made about moving to scale12; or expe-
rience with implementing an intervention may need to 
be documented in order to strengthen implementation 
or uptake.13 Agencies also commonly commission ‘end 
of programme’ evaluations aimed at providing evidence 
of impact and cost-effectiveness in order to motivate host 
countries to take over funding of a programme.
Dissemination of implementation research is influ-
enced by the perceived purposes of the research and 
the types of outputs expected by different stakeholders. 
Researchers may want to publish peer-reviewed articles, 
funders want a report and impact analysis, governments 
and partners often want presentations and briefs to 
accompany a report. A clear understanding of expected 
outputs is therefore needed when undertaking imple-
mentation research, including the way in which different 
stakeholders can use the research findings.14
There are important ethical considerations in the 
dissemination of research findings: overt or covert 
restrictions on the dissemination of research findings 
raise dilemmas regarding data ownership and prevent 
the opportunity to learn from the research findings to 
improve implementation.12 Furthermore, if a govern-
ment or multilateral agency funds research with public 
money, it could be argued that there is an ethical respon-
sibility to make the findings publicly available regardless 
of the implications.
It is important for researchers to understand the types 
of decisions that may be taken as a consequence of 
research findings. For example, what might be at stake 
for the commissioning agency, the implementers or the 
government if the research findings highlight challenges 
with implementation, health systems constraints to imple-
mentation at scale, or no success or impact? Researchers 
also have obligations to ensure that their team have the 
necessary experience and competencies to carry out 
high-quality research that is defensible in the face of crit-
icism or alternative interpretations.
Understanding the purpose of the research is important 
for the commissioned researchers so that they can ask 
the most appropriate questions and can anticipate the 
consequences of various research findings. In box 2 we 
illustrate the inherent tensions arising from different 
expectations and views of the research purpose and how 
this may play out in disagreement about the research 
scope, interpretations of findings and dissemination of 
study findings.
reCommendaTions for implemenTaTion researCHers
Undertaking commissioned implementation research is 
likely to come with tensions relating to the differing inter-
ests of stakeholders including the commissioning agency, 
implementation agencies, host country governments 
Box 2 What is the purpose of the research and how will 
the findings be used?
A high-income country government has funded the scale-up of 
‘universal test and treat for HIV (UTT)’ in six countries in sub-
Saharan Africa. The grant period is 5 years and they have budgeted 
for an ‘end of grant’ evaluation in the final year. A university-based 
research agency from the Global South is awarded the research 
grant to undertake a mixed methods evaluation of progress with 
implementation of UTT in the focus countries. There are certain 
restrictions in the contract. First, the research questions were 
predetermined by the funder and, second, the researchers are 
required to obtain permission from the funder before any publication 
of the findings.
The researchers complete their fieldwork and submit the report to 
the funder. One of the main findings from the research is that the 
weak health systems in the countries are hindering scale-up of the 
programme, especially weak supply chain systems which result 
in stock-outs of HIV test kits and antiretrovirals. Since the funder 
plans to use the evaluation to lobby their constituents for continued 
funding, they, together with the country government, request that the 
researchers write short case studies highlighting areas of success. 
They also request that researchers not publish the findings related to 
health systems weaknesses.
The researchers, while cognisant of the risks to future funding for 
the programme, argue that publication of the health system-related 
findings is as important for reasons of scientific integrity, and could 
contribute important evidence for future decision-making, planning 
and resource allocation for HIV services in low-income, weak health 
systems. A discussion ensues between the researchers and the 
commissioning agency and a middle ground is reached where the 
health systems findings are published in a peer-reviewed journal 
following revisions to the satisfaction of the agency.
As illustrated here, in an environment of high donor dependence and 
short-term donor commitments, stakeholders, especially country 
governments, may be particularly interested in findings that support 
ongoing investment in programmes. Commissioned researchers 
therefore need to be cognisant of the purpose of the research and 
initiate discussions around the implications of the possible findings at 
the outset and there should be conflict resolution processes in place.
copyright.
 on O
ctober 23, 2019 at U











ealth: first published as 10.1136/bm




4 Doherty T, et al. BMJ Glob Health 2018;3:e000741. doi:10.1136/bmjgh-2018-000741
BMJ Global Health
and the commissioned researchers. Competing priori-
ties among stakeholders may give rise to contestation at 
various stages of the commissioned research, including 
the conception stage, implementation stage, interpreta-
tion of findings and the dissemination and utilisation of 
findings. Commissioned researchers from LMIC settings 
may feel (real or perceived) disempowerment in navi-
gating this complex terrain15 and this article attempts to 
describe some of these complexities.
In a critical reflection of the limited impact of global 
health development efforts on maternal health in LMICs, 
Mumtaz12 and colleagues argued that we need to learn 
from ‘successes and failures’, but that this would require 
a kind of collaboration which is currently absent (due 
to political, social and financial pressures in LMICs), 
where there is consensus among all stakeholders on the 
need for evidence of what works and what does not work, 
regardless of the implications.
In the absence of such consensus, we are advocating for 
researchers to be cognisant of the complexity of under-
taking commissioned implementation research in LMIC 
settings. We propose that asking key questions about the 
relationships among stakeholders involved in the research 
can help clarify the potential conflicts that may emerge. 
The focus of such discussions should be how the research 
can be conducted in a way that ensures the independence 
and integrity of the research process, how the objectives 
and needs of various stakeholders will be considered and 
what conflict resolution mechanisms are required. This 
may be particularly challenging given the economic reality 
that research institutions from the Global South experi-
ence, resulting in pressure to sacrifice negotiating ability in 
order not to jeopardise much needed research funding.6
Beyond supporting their own researchers in these 
negotiations, institutions from the Global South could 
also link together to support each other and to share strat-
egies and modified approaches to ensure fair research 
contracting and commissioning7 9 drawing on existing 
initiatives such as the Council on Health Research for 
Development which provides guidance on fair research 
contracting. Additional recommendations include 
strengthening accountability structures governing 
global health practice, the establishment of national 
ombudsman or mediating agencies and an international 
evaluation registry, similar to a clinical trial registry, to 
increase transparency and reduce selective reporting of 
programme evaluations.12
The political context of commissioning implementa-
tion research is a reality and the questions posed in this 
article could be useful for researchers when considering 
undertaking commissioned research and for engage-
ments with commissioning agencies. These questions 
could also spark open discussion between these stake-
holders towards the primary goal of strengthening health 
systems.
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